<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The incidence of FLT3 mutations (internal tandem duplication and Asp835) was investigated in bone marrow samples from 97 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> [(<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>); excluding cases with refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts in transformation] at the time of diagnosis and several time points thereafter </plain></SENT>
<SENT sid="1" pm="."><plain>Three patients had FLT3 mutations at presentation </plain></SENT>
<SENT sid="2" pm="."><plain>Forty-two patients progressed to <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), including the three patients with FLT3 mutations at <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> diagnosis </plain></SENT>
<SENT sid="3" pm="."><plain>Three additional patients acquired FLT3 mutations and progressed to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> in 1 month </plain></SENT>
<SENT sid="4" pm="."><plain>FLT3 mutations seem to be a critical additional genetic event that transforms a minority of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
</text></document>